{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:40:49Z","timestamp":1788784849988,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":2588,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1124\/mol.117.110379","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T00:10:22Z","timestamp":1507075822000},"page":"694-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease"],"prefix":"10.1016","volume":"92","author":[{"given":"Ravi","family":"Jahagirdar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Attwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Marusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Bendele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narmada","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin G.","family":"McLure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Gilham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Norek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik C.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman C.W.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Kulikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.117.110379_bib1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/ni.2072","article-title":"NF-\u03baB is 25","volume":"12","author":"Baltimore","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1124\/mol.117.110379_bib2","doi-asserted-by":"crossref","first-page":"14532","DOI":"10.1073\/pnas.1212264109","article-title":"Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors","volume":"109","author":"Bandukwala","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.117.110379_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2011.02.017","article-title":"Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells","volume":"34","author":"Bandukwala","year":"2011","journal-title":"Immunity"},{"key":"10.1124\/mol.117.110379_bib4","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.bbadis.2014.05.013","article-title":"I-BET151 selectively regulates IL-6 production","volume":"1842","author":"Barrett","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.117.110379_bib5","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: cause and immunobiology","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"10.1124\/mol.117.110379_bib6","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.4049\/jimmunol.1202838","article-title":"BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses","volume":"190","author":"Belkina","year":"2013","journal-title":"J Immunol"},{"key":"10.1124\/mol.117.110379_bib7","first-page":"377","article-title":"Animal models of rheumatoid arthritis","volume":"1","author":"Bendele","year":"2001","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1124\/mol.117.110379_bib8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1182\/blood.V91.1.258","article-title":"Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line","volume":"91","author":"Biswas","year":"1998","journal-title":"Blood"},{"issue":"86","key":"10.1124\/mol.117.110379_bib9","doi-asserted-by":"crossref","DOI":"10.3791\/51275-v","article-title":"Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice","author":"Bittner","year":"2014","journal-title":"J Vis Exp"},{"key":"10.1124\/mol.117.110379_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.molcel.2014.08.024","article-title":"NF-\u03baB directs dynamic super enhancer formation in inflammation and atherogenesis","volume":"56","author":"Brown","year":"2014","journal-title":"Mol Cell"},{"key":"10.1124\/mol.117.110379_bib11","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1073\/pnas.91.9.3652","article-title":"Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant","volume":"91","author":"Carr","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.117.110379_bib12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nri2438","article-title":"Immunotherapy of autoimmunity and cancer: the penalty for success","volume":"8","author":"Caspi","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/mol.117.110379_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nri2761","article-title":"Therapeutic antibodies for autoimmunity and inflammation","volume":"10","author":"Chan","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/mol.117.110379_bib14","doi-asserted-by":"crossref","unstructured":"Chen K, Campfield BT, Wenzel SE, McAleer JP, Kreindler JL, Kurland G, Gopal R, Wang T, Chen W, Eddens T et al. (2016) Antiinflammatory effects of bromodomain and extraterminal domain inhibition in cystic fibrosis lung inflammation. JCI insight 1:e87168.","DOI":"10.1172\/jci.insight.87168"},{"key":"10.1124\/mol.117.110379_bib15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.117.110379_bib16","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1124\/mol.117.110379_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clim.2008.08.018","article-title":"The effects of IL-6 on CD4 T cell responses","volume":"130","author":"Dienz","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1124\/mol.117.110379_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1124\/mol.117.110379_bib19","first-page":"112","article-title":"Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design","volume":"59","author":"Emerson","year":"2009","journal-title":"Comp Med"},{"key":"10.1124\/mol.117.110379_bib20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","article-title":"Histone recognition and large-scale structural analysis of the human bromodomain family","volume":"149","author":"Filippakopoulos","year":"2012","journal-title":"Cell"},{"key":"10.1124\/mol.117.110379_bib21","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1124\/mol.117.110379_bib22","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.4049\/jimmunol.181.7.4648","article-title":"Swift entry of myelin-specific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis","volume":"181","author":"Furtado","year":"2008","journal-title":"J Immunol"},{"key":"10.1124\/mol.117.110379_bib23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.chembiol.2014.05.009","article-title":"Selective chemical modulation of gene transcription favors oligodendrocyte lineage progression","volume":"21","author":"Gacias","year":"2014","journal-title":"Chem Biol"},{"key":"10.1124\/mol.117.110379_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2016.01.036","article-title":"RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I\/HDL and represses pathways that contribute to cardiovascular disease","volume":"247","author":"Gilham","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1124\/mol.117.110379_bib25","unstructured":"Hansen HC (2011) inventor, Resverlogix Corporation, assignee. Compounds for the prevention and treatment of cardiovascular diseases. U.S. patent 8,053,440. 2011 Nov 8."},{"key":"10.1124\/mol.117.110379_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cellimm.2005.11.002","article-title":"Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis","volume":"237","author":"Hofstetter","year":"2005","journal-title":"Cell Immunol"},{"key":"10.1124\/mol.117.110379_bib27","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/MCB.01365-08","article-title":"Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA","volume":"29","author":"Huang","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.117.110379_bib28","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/ar2319","article-title":"Collagen-induced arthritis in C57BL\/6 mice is associated with a robust and sustained T-cell response to type II collagen","volume":"9","author":"Inglis","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1124\/mol.117.110379_bib29","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1093\/nar\/gku449","article-title":"Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation","volume":"42","author":"Itzen","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/mol.117.110379_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2014.06.008","article-title":"A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice","volume":"236","author":"Jahagirdar","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1124\/mol.117.110379_bib31","first-page":"439","article-title":"FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration","volume":"2","author":"Kataoka","year":"2005","journal-title":"Cell Mol Immunol"},{"key":"10.1124\/mol.117.110379_bib32","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/nprot.2006.393","article-title":"Collagen antibody-induced arthritis","volume":"1","author":"Khachigian","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1124\/mol.117.110379_bib33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbrc.2016.06.021","article-title":"RVX-297- a novel BD2 selective inhibitor of BET bromodomains","volume":"477","author":"Kharenko","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.117.110379_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"10.1124\/mol.117.110379_bib35","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama","year":"2006","journal-title":"J Immunol"},{"key":"10.1124\/mol.117.110379_bib36","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.20080159","article-title":"IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition","volume":"205","author":"Kroenke","year":"2008","journal-title":"J Exp Med"},{"key":"10.1124\/mol.117.110379_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1381612820666140825122036","article-title":"Role of synovial fibroblasts in rheumatoid arthritis","volume":"21","author":"Lefevre","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1124\/mol.117.110379_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneuroim.2008.08.012","article-title":"Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses","volume":"204","author":"Marusic","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1124\/mol.117.110379_bib39","doi-asserted-by":"crossref","first-page":"42106","DOI":"10.1074\/jbc.M308586200","article-title":"HMGA1 co-activates transcription in B cells through indirect association with DNA","volume":"278","author":"McCarthy","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.117.110379_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083190","article-title":"RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist","volume":"8","author":"McLure","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/mol.117.110379_bib41","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1084\/jem.20130376","article-title":"BET bromodomain inhibition suppresses TH17-mediated pathology","volume":"210","author":"Mele","year":"2013","journal-title":"J Exp Med"},{"key":"10.1124\/mol.117.110379_bib42","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1073\/pnas.1108190108","article-title":"Targeting MYC dependence in cancer by inhibiting BET bromodomains","volume":"108","author":"Mertz","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.117.110379_bib43","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J Immunol"},{"key":"10.1124\/mol.117.110379_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40256-015-0146-z","article-title":"Effect of the BET protein inhibitor, RVX-208, on progression of coronary atherosclerosis: results of the phase 2b, randomized, double-blind, multicenter, ASSURE trial","volume":"16","author":"Nicholls","year":"2016","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1124\/mol.117.110379_bib45","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nature09589","article-title":"Suppression of inflammation by a synthetic histone mimic","volume":"468","author":"Nicodeme","year":"2010","journal-title":"Nature"},{"key":"10.1124\/mol.117.110379_bib46","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1517\/13543784.2015.1083010","article-title":"An evaluation of RVX-208 for the treatment of atherosclerosis","volume":"24","author":"Nikolic","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/mol.117.110379_bib47","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.4049\/jimmunol.181.6.3750","article-title":"Cutting edge: th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis","volume":"181","author":"O\u2019Connor","year":"2008","journal-title":"J Immunol"},{"key":"10.1124\/mol.117.110379_bib48","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1101\/gad.1477006","article-title":"Phosphorylation and functions of the RNA polymerase II CTD","volume":"20","author":"Phatnani","year":"2006","journal-title":"Genes Dev"},{"key":"10.1124\/mol.117.110379_bib49","doi-asserted-by":"crossref","first-page":"19754","DOI":"10.1073\/pnas.1310658110","article-title":"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain","volume":"110","author":"Picaud","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.117.110379_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2474-10-46","article-title":"Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis","volume":"10","author":"Plum","year":"2009","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1124\/mol.117.110379_bib52","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1074\/jbc.M111.282855","article-title":"Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes","volume":"287","author":"Schr\u00f6der","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.117.110379_bib53","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ni.2070","article-title":"Hierarchies of NF-\u03baB target-gene regulation","volume":"12","author":"Smale","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1124\/mol.117.110379_bib54","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.4049\/jimmunol.178.4.2589","article-title":"IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis","volume":"178","author":"Thakker","year":"2007","journal-title":"J Immunol"},{"key":"10.1124\/mol.117.110379_bib55","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.4049\/jimmunol.1401635","article-title":"Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation","volume":"194","author":"Toniolo","year":"2015","journal-title":"J Immunol"},{"key":"10.1124\/mol.117.110379_bib56","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1124\/mol.117.110379_bib57","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2008.12.009","article-title":"Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells","volume":"30","author":"Wei","year":"2009","journal-title":"Immunity"},{"key":"10.1124\/mol.117.110379_bib58","first-page":"207","article-title":"Collagen-induced arthritis as a model for rheumatoid arthritis","volume":"98","author":"Williams","year":"2004","journal-title":"Methods Mol Med"},{"key":"10.1124\/mol.117.110379_bib59","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2005.06.029","article-title":"Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4","volume":"19","author":"Yang","year":"2005","journal-title":"Mol Cell"},{"key":"10.1124\/mol.117.110379_bib60","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense","volume":"194","author":"Ye","year":"2001","journal-title":"J Exp Med"},{"key":"10.1124\/mol.117.110379_bib61","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.imlet.2015.05.016","article-title":"Targeting bromodomain-containing protein 4 (BRD4) benefits rheumatoid arthritis","volume":"166","author":"Zhang","year":"2015","journal-title":"Immunol Lett"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24007089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24007089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.117.110379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T17:22:55Z","timestamp":1740763375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24007089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0026895X24007089"],"URL":"https:\/\/doi.org\/10.1124\/mol.117.110379","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.117.110379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s).","name":"copyright","label":"Copyright"}]}}